Bioherent was founded in 2021 as a technology company by researchers of the University of Málaga with entirely different backgrounds and fields of expertise such as Engineering (Photonics & Telecommunications), Organic Chemistry, and Medicine to target the sensitive and reliable detection of drug allergy in the clinical environment.
This company was created by members of three research groups from the University of Málaga and Bionand, the Andalusian Centre for Nanomedicine & Biotechnology: the Photonics and Radiofrequency Laboratory, the Biomimetic Dendrimers and Photonic Laboratory, and the Nanostructures For Diagnosing and Treatment of Allergic Diseases Laboratory.
Nowadays, drug allergies, such as betalactam antibiotics are difficult to verify with modern diagnostic techniques. It is estimated that 70-90% of people who are identified as betalactam allergy sufferers are in fact not allergic at all. Besides, high costs and time consuming preparation steps make those techniques especially unpractical for the clinical environment. Our team develops a highly sensitive, in-vitro, low-cost medical diagnostic structures. This low time consuming plug-n-play solution will revolutionise drug allergy tests as we know them.
We are an international and multidisciplinary team and currently searching for young, motivated, and innovative minds to join on our journey.